Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials

doi:10.3736/jintegrmed2013056

Abstract

Background

Due to safety concerns and side effects of many antidepressant medications, herbal psychopharmacology research has increased, and herbal remedies are becoming increasingly popular as alternatives to prescribed medications for the treatment of major depressive disorder (MDD). Of these, accumulating trials reveal positive effects of the spice saffron (Crocus sativus L.) for the treatment of depression. A comprehensive and statistical review of the clinical trials examining the effects of saffron for treatment of MDD is warranted.

Objective

The purpose of this study was to conduct a meta-analysis of published randomized controlled trials examining the effects of saffron supplementation on symptoms of depression among participants with MDD.

Search strategy

We conducted electronic and non-electronic searches to identify all relevant randomized, double-blind controlled trials. Reference lists of all retrieved articles were searched for relevant studies.

Inclusion criteria

The criteria for study selection included the following: (1) adults (aged 18 and older) with symptoms of depression, (2) randomized controlled trial, (3) effects of saffron supplementation on depressive symptoms examined, and (4) study had either a placebo control or antidepressant comparison group.

Data extraction and analysis

Using random effects modeling procedures, we calculated weighted mean effect sizes separately for the saffron supplementation vs placebo control groups, and for the saffron supplementation vs antidepressant groups. The methodological quality of all studies was assessed using the Jadad score. The computer software Comprehensive Meta-analysis 2 was used to analyze the data.

Results

Based on our pre-specified criteria, five randomized controlled trials (n = 2 placebo controlled trials, n = 3 antidepressant controlled trials) were included in our review. A large effect size was found for saffron supplementation vs placebo control in treating depressive symptoms (M ES = 1.62, P < 0.001), revealing that saffron supplementation significantly reduced depression symptoms compared to the placebo control. A null effect size was evidenced between saffron supplementation and the antidepressant groups (M ES = -0.15) indicating that both treatments were similarly effective in reducing depression symptoms. The mean Jadad score was 5 indicating high quality of trials.

Conclusion

Findings from clinical trials conducted to date indicate that saffron supplementation can improve symptoms of depression in adults with MDD. Larger clinical trials, conducted by research teams outside of Iran, with long-term follow-ups are needed before firm conclusions can be made regarding saffron’s efficacy and safety for treating depressive symptoms.

Key words: Crocus, Depressive disorder, Dietary supplements, Mood disorders, Quality of life, Medicine, Herbal, Meta-analysis

Heather Ann Hausenblas, Debbie Saha, Pamela Jean Dubyak, Stephen Douglas Anton. Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Chinese Integrative Medicine, 2013, 11(6): 377-383.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jintegrmed2013056

http://www.jcimjournal.com/EN/Y2013/V11/I6/377

[1]	Hirschfeld R . Depression epidemiology and its treatment evolution[J]. J Clin Psychiatry, 2012,73(10):e29 doi: 10.4088/JCP.11096tx3c
[2]	Maj M . Development and validation of the current concept of major depression[J]. Psychopathology, 2012,45(3):135-146 doi: 10.1159/000329100
[3]	Maj M . Validity and clinical utility of the current operational characterization of major depression[J]. Int Rev Psychiatry, 2012,24(6):530-537 doi: 10.3109/09540261.2012.712952
[4]	González HM, Tarraf W . Comorbid cardiovascular disease and major depression among ethnic and racial groups in the United States[J]. Int Psychogeriatr, 2013,25(5):833-841 doi: 10.1017/S1041610212002062
[5]	Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication.The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication(NCS-R)[J]. JAMA, 2003,289(23):3095-3105 doi: 10.1001/jama.289.23.3095
[6]	Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA . National trends in the outpatient treatment of depression[J]. JAMA, 2002,287(2):203-209 doi: 10.1001/jama.287.2.203
[7]	Williams JW Jr, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J . Primary care physicians’ approach to depressive disorders. Effects of physician specialty and practice structure[J]. Arch Fam Med, 1999,8(1):58-67 doi: 10.1001/archfami.8.1.58
[8]	Ferguson JM . SSRI antidepressant medications: adverse effects and tolerability[J]. Prim Care Companion J Clin Psychiatry, 2001,3(1):22-27 doi: 10.4088/PCC.v03n0105
[9]	Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A . Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence[J]. Eur Neuropsychopharmacol, 2011,21(12):841-860 doi: 10.1016/j.euroneuro.2011.04.002
[10]	Dwyer AV, Whitten DL, Hawrelak JA . Herbal medicines, other than St. John’s Wort, in the treatment of depression: a systematic review[J]. Altern Med Rev, 2011,16(1):40-49
[11]	Georgiadou G, Tarantilis PA, Pitsikas N . Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder[J]. Neurosci Lett, 2012,528(1):27-30 doi: 10.1016/j.neulet.2012.08.081
[12]	Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, Qin LP . Antidepressant properties of bioactive fractions from the extract of Crocus sativus L[J]. J Nat Med, 2010,64(1):24-30 doi: 10.1007/s11418-009-0360-6
[13]	Kamalipour M, Jamshidi AH, Akhondzadeh S . Antidepressant effect of Crocus sativus: An evidence based review[J]. J Med Plants, 2010,9(6):35-38
[14]	Modabbernia A, Akhondzadeh S . Saffron, passionflower, valerian and sage for mental health[J]. Psychiatr Clin North Am, 2013,36(1):85-91 doi: 10.1016/j.psc.2012.12.007
[15]	Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. Ann Intern Med, 2009,151(4):264-269, W64 doi: 10.7326/0003-4819-151-4-200908180-00135
[16]	Conn VS, Valentine JC, Cooper HM, Rantz MJ . Grey literature in meta-analyses[J]. Nurs Res, 2003,52(4):256-261 doi: 10.1097/00006199-200307000-00008
[17]	Ulbricht C, Conquer J, Costa D, Hollands W, Iannuzzi C, Isaac R, Jordan JK, Ledesma N, Ostroff C, Serrano JM, Shaffer MD, Varghese M . An evidence-based systematic review of saffron(Crocus sativus) by the Natural Standard Research Collaboration[J]. J Diet Suppl, 2011,8(1):58-114 doi: 10.3109/19390211.2011.547666
[18]	Akhondzadeh Basti A, Ghoreishi SA, Noorbala AA, Akhondzadeh SH, Rezazadeh SH . Petal and stigma of Crocus sativus L. in the treatment of depression: a pilot double-blind randomized trial[J]. J Med Plants, 2008,7(4):29-36
[19]	Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, Khani M . Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial[J]. Phytother Res, 2005,19(2):148-151 doi: 10.1002/(ISSN)1099-1573
[20]	Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S . Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2007,31(2):439-442 doi: 10.1016/j.pnpbp.2006.11.010
[21]	Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S . Crocus sativus L.(petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial[J]. Phytomedicine, 2006,13(9-10):607-611 doi: 10.1016/j.phymed.2006.08.006
[22]	Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH . Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial[J]. J Ethnopharmacol, 2005,97(2):281-284 doi: 10.1016/j.jep.2004.11.004
[23]	Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F . Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816][J]. BMC Complement Altern Med, 2004,4:12 doi: 10.1186/1472-6882-4-12
[24]	Morris S . Estimating effect sizes from pretest-posttest-control group designs[J]. Organ Res Methods, 2008,11(2):364-386 doi: 10.1177/1094428106291059
[25]	Hedges L, Olkin I, Statistiker M. Statistical methods for meta-analysis. New York: Academic Press. 1985.
[26]	Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D , G?tzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials).The revised CONSORT statement for reporting randomized trials: explanation and elaboration[J]. Ann Intern Med, 2001,134(8):663-694 doi: 10.7326/0003-4819-134-8-200104170-00012
[27]	Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ , McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1):1-12. doi: 10.1016/0197-2456(95)00134-4
[28]	Berger F, Hensel A, Nieber K . Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices[J]. Neuroscience, 2011,180:238-247 doi: 10.1016/j.neuroscience.2011.02.037
[29]	Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S . Crocus sativus L.(saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial[J]. BJOG, 2008,115(4):515-519 doi: 10.1111/bjo.2008.115.issue-4
[30]	Joshi JV, Pandey SN, Galvankar P, Gogate JA . Prevalence of premenstrual symptoms: Preliminary analysis and brief review of management strategies[J]. J Midlife Health, 2010,1(1):30-34
[31]	Tschudin S, Bertea PC, Zemp E . Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample[J]. Arch Womens Ment Health, 2010,13(6):485-494 doi: 10.1007/s00737-010-0165-3

Related Articles 15

[1]	Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2]	Ming-min Xu, Pei Guo, Qing-yu Ma, Xuan Zhou, Yu-long Wei, Lu Wang, Yue Chen, Yu Guo. Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression? A systematic review and meta-analysis. Journal of Integrative Medicine, 2022, 20(4): 305-320.
[3]	Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[4]	Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375.
[5]	Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[6]	Vibha Malhotra, Joanna Harnett, Erica McIntyre, Amie Steel, Keith Wong, Bandana Saini. To “tell or not to tell”—Exploring disclosure about medicine use by people living with sleep disorders. Journal of Integrative Medicine, 2022, 20(4): 338-347.
[7]	Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[8]	Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[9]	Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[10]	Ting-ting Lu, Cun-cun Lu, Mei-xuan Li, Li-xin Ke, Hui Cai, Ke-hu Yang. Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map. Journal of Integrative Medicine, 2022, 20(3): 213-220.
[11]	Mohammad Fazil, Sadia Nikhat. Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective. Journal of Integrative Medicine, 2022, 20(2): 91-95.
[12]	Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[13]	Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.
[14]	Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33.
[15]	Mahlagha Dehghan, Alireza Ghanbari, Fatemeh Ghaedi Heidari, Parvin Mangalian, Mohammad Ali Zakerid. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. Journal of Integrative Medicine, 2022, 20(1): 45-51.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2]	Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3]	Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4]	Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5]	Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6]	Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7]	Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8]	Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9]	Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10]	Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278